Finance entity

Brookings Institution

organization

Their average consequence score of 7.5 runs above the beat's 6.3 for that window. Alibaba Group Holding is the most frequent co-covered peer, appearing in 1 of the 4 tracked stories. Across a 139-day span, the pace is roughly 0.2 stories per week.

Last mentioned: Jul 9, 2026

Entity pulse

Recent coverage · Brookings Institution

4 stories
7.5 avg impact
0% positive
50% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 50 percentage points.

  • 50% neutral
  • 50% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Brookings Institution

Their average consequence score of 7.5 runs above the beat's 6.3 for that window. Alibaba Group Holding is the most frequent co-covered peer, appearing in 1 of the 4 tracked stories. Across a 139-day span, the pace is roughly 0.2 stories per week. markets accounts for 2 of the 4 tracked stories, while 1 other category carries the remainder. They are better corroborated than the beat average, carrying 2.8 original sources each against 2.7 for the same window. This profile follows 4 Finance stories mentioning Brookings Institution across the period from February 21, 2026 to July 9, 2026.

Stories tracked
4
Per week
0.2
Sources per story
2.8

Computed from the 4 stories linked to this entity, with beat comparisons drawn from all 3243 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Brookings Institution. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning Brookings Institution 4

Financial Regulation Bearish

US Lawmakers Sound Alarm Over Chinese Dominance in Pharmaceutical Supply Chain

The House Select Committee on China has warned that Beijing is executing a strategic 'playbook' to dominate the global pharmaceutical market, mirroring its previous successes in rare earths and electric vehicles. With Chinese medical revenue projected to reach $2.1 trillion by 2030, US officials are weighing the national security risks of a supply chain heavily dependent on Chinese-made active pharmaceutical ingredients.

3 sources

Brookings Institution is linked from 4 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.